BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 7517211)

  • 21. Diagnostic immunophenotype of acute promyelocytic leukemia before and early during therapy with all-trans retinoic acid.
    Horna P; Zhang L; Sotomayor EM; Lancet JE; Moscinski LC
    Am J Clin Pathol; 2014 Oct; 142(4):546-52. PubMed ID: 25239423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A microgranular variant of acute promyelocytic leukemia with atypical morpho-cytochemical features and an early myeloid immunophenotype.
    Stasi R; Bruno A; Venditti A; Del Poeta G; Aronica G; Cox MC; Maffei L; Catalano G; Zangrilli D; Amadori S
    Leuk Res; 1997 Jun; 21(6):575-80. PubMed ID: 9279368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
    Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphoid subsets in acute myeloid leukemias: increased number of cells with NK phenotype and normal T-cell distribution.
    Vidriales MB; Orfao A; López-Berges MC; González M; Hernandez JM; Ciudad J; López A; Moro MJ; Martínez M; San Miguel JF
    Ann Hematol; 1993 Nov; 67(5):217-22. PubMed ID: 7694663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry.
    Baer MR; Stewart CC; Lawrence D; Arthur DC; Mrózek K; Strout MP; Davey FR; Schiffer CA; Bloomfield CD
    Leukemia; 1998 Mar; 12(3):317-25. PubMed ID: 9529125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
    Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
    Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children.
    Hurwitz CA; Raimondi SC; Head D; Krance R; Mirro J; Kalwinsky DK; Ayers GD; Behm FG
    Blood; 1992 Dec; 80(12):3182-8. PubMed ID: 1467524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M; Kusenda J; Babusikova O
    Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunophenotypic pattern of myeloid populations by flow cytometry analysis.
    Gorczyca W; Sun ZY; Cronin W; Li X; Mau S; Tugulea S
    Methods Cell Biol; 2011; 103():221-66. PubMed ID: 21722806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as FAB-M3 acute myeloid leukemia.
    Paietta E; Gallagher RE; Wiernik PH
    Blood; 1994 Oct; 84(8):2824-5. PubMed ID: 7522645
    [No Abstract]   [Full Text] [Related]  

  • 31. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
    Janossy G; Coustan-Smith E; Campana D
    Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): does it prove true for the M3-variant?
    Exner M; Thalhammer R; Kapiotis S; Mitterbauer G; Knöbl P; Haas OA; Jäger U; Schwarzinger I
    Cytometry; 2000 Apr; 42(2):106-9. PubMed ID: 10797447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The triple-negative (CD34-/HLA-DR-/CD11b-) profile rapidly and specifically identifies an acute promyelocytic leukemia.
    Rahman K; Gupta R; Singh MK; Sarkar MK; Gupta A; Nityanand S
    Int J Lab Hematol; 2018 Apr; 40(2):144-151. PubMed ID: 28984423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural killer cell acute leukemia with myeloid antigen expression. A previously undescribed form of acute leukemia.
    Dunphy CH; Gregowicz AJ; Rodriguez G
    Am J Clin Pathol; 1995 Aug; 104(2):212-5. PubMed ID: 7639197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural killer cytotoxicity and lymphocyte subpopulations in patients with acute leukemia.
    Parrado A; Casares S; Rodríguez-Fernández JM
    Leuk Res; 1994 Mar; 18(3):191-7. PubMed ID: 7511191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunophenotypic features in 143 cases of acute promyelocytic leukemia].
    Sun HM; Qian SX; Wu YJ; Qiao C; Hong M; Fan L; Yang H; Zhang JF; Zhang SJ; Wu HX; Qiu HX; Lu H; Xu W; Sheng RL; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):176-9. PubMed ID: 19236773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of cell-surface antigens in acute promyelocytic leukaemia.
    Paietta E
    Best Pract Res Clin Haematol; 2003 Sep; 16(3):369-85. PubMed ID: 12935957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An unusual case of CD4+ CD7+ CD56+ acute leukemia with overlapping features of type 2 dendritic cell (DC2) and myeloid/NK cell precursor acute leukemia.
    Anargyrou K; Paterakis G; Boutsis D; Politou M; Papadhimitriou SI; Siakandaris M; Vassiliadis J; Androulakis A; Meletis J; Rombos J; Tassiopoulou A; Vaiopoulos G
    Eur J Haematol; 2003 Oct; 71(4):294-8. PubMed ID: 12950240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta.
    Yoneda N; Tatsumi E; Teshigawara K; Nagata S; Nagano T; Kishimoto Y; Kimura T; Yasunaga K; Yamaguchi N
    Am J Hematol; 1994 Apr; 45(4):310-20. PubMed ID: 7513945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinicopathological features in HLA-DR-negative acute myeloid leukemia].
    Muroi K; Yoshida M; Suzuki T; Amemiya Y; Hatake K; Miura Y
    Rinsho Ketsueki; 1997 Aug; 38(8):631-7. PubMed ID: 9311267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.